Literature DB >> 21256307

Artificial surface-induced inflammation relies on complement factor 5: proof from a deficient person.

Grethe Bergseth1, John D Lambris, Tom Eirik Mollnes, Knut Tore Lappegård.   

Abstract

BACKGROUND: Exposing blood to artificial surfaces results in an inflammatory response, including complement activation and cytokine release. The aim of this investigation was to study complement-dependency and independency in artificial surface-induced inflammation in human whole blood from a patient with a genetic deficiency of complement factor 5 (C5).
METHODS: Whole blood from a C5-deficient patient, C5 protein reconstituted blood, and blood from a control subject was used. The complement inhibitor compstatin (C3 inhibitor) and a C5a receptor antagonist were used to block complement. Blood was circulated in closed loops of polyvinyl chloride tubing. Leukocyte CD11b expression and release of granule enzymes (myeloperoxidase, elastase, lactoferrin), cytokines (interleukins, chemokines, and growth factors; n = 27) as well as complement activation were measured after incubation.
RESULTS: In C5-deficient blood, there was no formation of the terminal complement complex, as opposed to reconstituted or control blood. Release of granule enzymes was partly dependent on C3, revealed by a compstatin-dependent effect in C5-deficient blood, and partly C5a-dependent as evident from the reconstitution and control blood. The chemokines interleukin-8 and monocyte chemoattractant protein-1 were also highly complement dependent, the effect being C5a-mediated, whereas platelet-derived and vascular endothelial growth factors were partly complement dependent. Interferon-γ increased in a complement-independent manner, whereas the rest of the cytokines did not respond to the surface. Leukocyte expression of CD11b was only marginally increased in deficient blood exposed to the surface, whereas reconstitution induced a considerable, C5a-dependent increase, comparable with that of the control.
CONCLUSIONS: The polyvinyl chloride surface induced a defined inflammatory response, which largely depended on C5. Copyright Â
© 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21256307      PMCID: PMC3123536          DOI: 10.1016/j.athoracsur.2010.10.084

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  21 in total

1.  A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin.

Authors:  T E Mollnes; J Riesenfeld; P Garred; E Nordström; K Høgåsen; E Fosse; O Götze; M Harboe
Journal:  Artif Organs       Date:  1995-09       Impact factor: 3.094

Review 2.  Inflammatory response to cardiopulmonary bypass.

Authors:  L H Edmunds
Journal:  Ann Thorac Surg       Date:  1998-11       Impact factor: 4.330

3.  Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.

Authors:  C S Rinder; H M Rinder; B R Smith; J C Fitch; M J Smith; J B Tracey; L A Matis; S P Squinto; S A Rollins
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Detection and quantification of the terminal C5b-9 complex of human complement by a sensitive enzyme-linked immunosorbent assay.

Authors:  T E Mollnes; T Lea; M Harboe
Journal:  Scand J Immunol       Date:  1984-08       Impact factor: 3.487

5.  Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass.

Authors:  J C Fitch; S Rollins; L Matis; B Alford; S Aranki; C D Collard; M Dewar; J Elefteriades; R Hines; G Kopf; P Kraker; L Li; R O'Hara; C Rinder; H Rinder; R Shaw; B Smith; G Stahl; S K Shernan
Journal:  Circulation       Date:  1999 Dec 21-28       Impact factor: 29.690

6.  C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect.

Authors:  Eva Delgado-Cerviño; Gumersindo Fontán; Margarita López-Trascasa
Journal:  Mol Immunol       Date:  2005-01       Impact factor: 4.407

7.  Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation.

Authors:  Tom Eirik Mollnes; Ole-Lars Brekke; Michael Fung; Hilde Fure; Dorte Christiansen; Grethe Bergseth; Vibeke Videm; Knut Tore Lappegård; Jörg Köhl; John D Lambris
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

8.  Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation.

Authors:  R Solberg; T Scholz; V Videm; C Okkenhaug; A O Aasen
Journal:  Transpl Int       Date:  1998       Impact factor: 3.782

9.  Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.

Authors:  Knut Tore Lappegård; Michael Fung; Grethe Bergseth; Johan Riesenfeld; Tom Eirik Mollnes
Journal:  Ann Thorac Surg       Date:  2004-07       Impact factor: 4.330

10.  Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.

Authors:  Knut Tore Lappegård; Michael Fung; Grethe Bergseth; Johan Riesenfeld; John D Lambris; Vibeke Videm; Tom Eirik Mollnes
Journal:  Ann Thorac Surg       Date:  2004-03       Impact factor: 4.330

View more
  8 in total

1.  Gingival Exudatome Dynamics Implicate Inhibition of the Alternative Complement Pathway in the Protective Action of the C3 Inhibitor Cp40 in Nonhuman Primate Periodontitis.

Authors:  Nagihan Bostanci; Kai Bao; Xiaofei Li; Tomoki Maekawa; Jonas Grossmann; Christian Panse; Ruel A Briones; Ranillo R G Resuello; Joel V Tuplano; Cristina A G Garcia; Edimara S Reis; John D Lambris; George Hajishengallis
Journal:  J Proteome Res       Date:  2018-08-29       Impact factor: 4.466

2.  Activation of polymorphonuclear leukocytes by candidate biomaterials for an implantable glucose sensor.

Authors:  Andrey Sokolov; Bernt Christian Hellerud; John D Lambris; Erik A Johannessen; Tom Eirik Mollnes
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

3.  Self-assembling surfaces of blood-contacting materials.

Authors:  Roman Major
Journal:  J Mater Sci Mater Med       Date:  2012-12-11       Impact factor: 3.896

Review 4.  The Complement System in Dialysis: A Forgotten Story?

Authors:  Felix Poppelaars; Bernardo Faria; Mariana Gaya da Costa; Casper F M Franssen; Willem J van Son; Stefan P Berger; Mohamed R Daha; Marc A Seelen
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

Review 5.  Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay Between Innate and Adaptive Immune Dysfunction.

Authors:  Vincenzo Losappio; Rossana Franzin; Barbara Infante; Giulia Godeas; Loreto Gesualdo; Alberto Fersini; Giuseppe Castellano; Giovanni Stallone
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

6.  Neuroinflammatory Gene Expression Analysis Reveals Pathways of Interest as Potential Targets to Improve the Recording Performance of Intracortical Microelectrodes.

Authors:  Sydney Song; Brianna Regan; Evon S Ereifej; E Ricky Chan; Jeffrey R Capadona
Journal:  Cells       Date:  2022-07-30       Impact factor: 7.666

Review 7.  Obstacles in haemocompatibility testing.

Authors:  W van Oeveren
Journal:  Scientifica (Cairo)       Date:  2013-05-07

8.  Intradialytic Complement Activation Precedes the Development of Cardiovascular Events in Hemodialysis Patients.

Authors:  Felix Poppelaars; Mariana Gaya da Costa; Bernardo Faria; Stefan P Berger; Solmaz Assa; Mohamed R Daha; José Osmar Medina Pestana; Willem J van Son; Casper F M Franssen; Marc A Seelen
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.